程序性细胞死亡蛋白 1 抑制剂治疗背景下的新型皮肤爆发。
关键词: NSCLC, non-small-cell lung cancer PD-1 inhibitor PD1, programmed cell death protein 1 drug eruption fixed drug eruption immunotherapy lichen sclerosus nivolumab pembrolizumab post-herpetic isotopic response pseudolymphoma rash scleredema skin toxicity
来 源:
DOI:10.1016/j.jdcr.2022.11.020
PDF(Pubmed)